Flavonoids | Quintile of intake | p for trend | ||||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | ||
Total flavonoids | ||||||
 cancer | ||||||
  No. of deaths | 186 | 223 | 235 | 243 | 265 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.22 (1.00–1.48) | 1.27 (1.05–1.54) | 1.27 (1.05–1.54) | 1.43 (1.19–1.73) | < 0.001 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.18 (0.97–1.44) | 1.17 (0.96–1.42) | 1.13 (0.93–1.38) | 1.19 (0.97–1.44) | 0.19 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.03 (0.79–1.35) | 1.07 (0.82–1.38) | 1.11 (0.85–1.44) | 1.04 (0.80–1.35) | 0.64 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.36 (1.01–1.82) | 1.19 (0.89–1.60) | 1.08 (0.80–1.46) | 1.23 (0.91–1.65) | 0.62 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.08 (0.85–1.35) | 1.12 (0.90–1.38) | 1.11 (0.89–1.37) | 1.13 (0.91–1.40) | 0.28 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.66 (1.07–3.79) | 1.41 (0.88–2.23) | 1.14 (0.70–1.97) | 1.28 (0.78–2.11) | 0.86 |
 GI cancer | ||||||
  No. of deaths | 108 | 123 | 123 | 145 | 143 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.17 (0.90–1.52) | 1.16 (0.90–1.51) | 1.32 (1.02–1.69) | 1.35 (1.05–1.73) | 0.01 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.12 (0.86–1.45) | 1.02 (0.78–1.32) | 1.11 (0.86–1.44) | 1.04 (0.80–1.35) | 0.80 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.85 (0.59–1.24) | 0.97 (0.68–1.38) | 1.04 (0.73–1.48) | 0.80 (0.55–1.15) | 0.53 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.41 (0.98–2.04) | 0.96 (0.65–1.42) | 1.09 (0.75–1.59) | 1.20 (0.82–1.74) | 0.81 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.00 (0.85–1.35) | 0.97 (0.73–1.28) | 1.06 (0.81–1.40) | 0.99 (0.74–1.31) | 0.89 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 2.01 (1.06–3.79) | 1.36 (0.68–2.71) | 1.35 (0.67–2.70) | 1.26 (0.61–2.60) | 0.98 |
 Other cancer | ||||||
  No. of deaths | 78 | 100 | 112 | 98 | 122 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.28 (0.95–1.73) | 1.42 (1.07–1.90) | 1.21 (0.90–1.63) | 1.55 (1.17–2.07) | 0.01 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.27 (0.99–1.71) | 1.38 (1.03–1.85) | 1.14 (0.84–1.55) | 1.39 (1.53–1.88) | 0.10 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.25 (0.85–1.83) | 1.78 (0.80–1.73) | 1.17 (0.79–1.73) | 1.36 (0.93–2.00) | 0.20 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.27 (0.78–2.05) | 1.58 (1.00–2.49) | 1.05 (0.63–1.71) | 1.27 (0.78–2.06) | 0.63 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.22 (0.87–1.72) | 1.35 (0.97–1.88) | 1.17 (0.83–1.64) | 1.36 (0.97–1.90) | 0.14 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.40 (0.75–2.59) | 1.44 (0.77–2.69) | 0.96 (0.48–1.93) | 1.32 (0.67–2.61) | 0.80 |
Flavonols | ||||||
 Cancer | ||||||
  No. of deaths | 186 | 226 | 223 | 253 | 265 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.23 (1.01–1.49) | 1.99 (0.98–1.45) | 1.31 (1.08–1.58) | 1.42 (1.18–1.71) | < 0.001 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.21 (0.99–1.47) | 1.11 (0.91–1.36) | 1.17 (0.96–1.42) | 1.19 (0.97–1.45) | 0.18 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.97 (0.74–1.26) | 0.98 (0.76–1.28) | 1.12 (0.87–1.44) | 0.96 (0.74–1.26) | 0.80 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.54 (1.15–2.07) | 1.21 (0.89–1.64) | 1.15 (0.85–1.55) | 1.35 (1.00–1.83) | 0.42 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.15 (0.75–1.34) | 1.04 (0.83–1.29) | 1.17 (0.94–1.45) | 1.15 (0.93–1.43) | 0.22 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.46 (0.93–2.27) | 1.48 (0.94–2.31) | 1.04 (0.63–1.71) | 1.16 (0.70–1.91) | 0.94 |
 GI cancer | ||||||
  No. of deaths | 109 | 120 | 120 | 151 | 143 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.12 (0.87–1.46) | 1.11 (0.86–1.44) | 1.34 (1.05–1.71) | 1.32 (1.03–1.70) | 0.009 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.10 (0.76–1.29) | 0.99 (0.76–1.29) | 1.14 (0.88–1.47) | 1.03 (0.79–1.35) | 0.71 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.77 (0.53–1.11) | 0.88 (0.60–1.23) | 1.10 (0.79–1.54) | 0.69 (0.48–1.00) | 0.42 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.54 (1.06) | 1.10 (0.74–1.63) | 1.07 (0.74–1.58) | 1.38 (0.94–2.02) | 0.53 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.00 (0.75–1.34) | 0.92 (0.69–1.23) | 1.13 (0.86–1.49) | 1.01 (0.76–1.34) | 0.61 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.74 (0.93–3.27) | 1.51 (0.79–2.89) | 1.06 (0.52–2.16) | 1.04 (0.50–2.15) | 0.58 |
 Other cancer | ||||||
  No. of deaths | 77 | 106 | 103 | 102 | 122 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.37 (1.02–1.84) | 1.31 (0.98–1.77) | 1.26 (0.94–1.70) | 1.56 (1.17–2.08) | 0.01 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.37 (1.01–1.84) | 1.28 (0.95–1.72) | 1.20 (0.88–1.62) | 1.40 (1.04–1.90) | 0.13 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.23 (0.84–1.80) | 1.15 (0.78–1.68) | 1.11 (0.75–1.64) | 1.35 (0.92–1.97) | 0.25 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.56 (0.97–2.51) | 1.40 (0.86–2.27) | 1.27 (0.78–2.07) | 1.31 (0.80–2.16) | 0.63 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.39 (0.99–1.95) | 1.23 (0.87–1.73) | 1.22 (0.86–1.71) | 1.38 (0.98–1.94) | 0.21 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.23 (0.65–2.30) | 1.43 (0.77–2.66) | 1.03 (0.51–2.05) | 1.30 (0.65–2.59) | 0.64 |
Flavan-3-ol monomers | ||||||
 Cancer | ||||||
  No. of deaths | 186 | 218 | 234 | 246 | 269 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.17 (0.96–1.42) | 1.27 (1.05–1.54) | 1.26 (1.04–1.52) | 1.44 (1.19–1.73) | < 0.001 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.40 (0.93–1.39) | 1.16 (0.95–1.41) | 1.12 (0.92–1.36) | 1.19 (0.98–1.44) | 0.14 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.01 (0.77–1.320 | 1.08 (0.83–1.39) | 1.07 (0.82–1.38) | 1.04 (0.80–1.35) | 0.66 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.30 (0.97–1.75) | 1.15 (0.85–1.55) | 1.12 (0.83–1.50) | 1.23 (0.92–1.66) | 0.45 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.02 (0.82–1.28) | 1.08 (0.87–1.33) | 1.09 (0.88–1.34) | 1.11 (0.90–1.38) | 0.25 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.73 (1.11–2.71) | 1.58 (0.99–2.51) | 1.18 (0.71–1.94) | 1.40 (0.85–2.30) | 0.67 |
 GI cancer | ||||||
  No. of deaths | 108 | 115 | 127 | 148 | 145 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.07 (0.82–1.39) | 1.21 (0.83–1.56) | 1.31 (1.02–1.68) | 1.35 (1.05–1.73) | 0.004 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.03 (0.79–1.34) | 1.04 (0.80–1.35) | 1.11 (0.86–1.43) | 1.03 (0.80–1.34) | 0.62 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.78 (0.53–1.14) | 0.99 (0.70–1.40) | 1.02 (0.72–1.44) | 0.79 (0.55–1.14) | 0.61 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.34 (0.92–1.95) | 0.98 (0.67–1.45) | 1.13 (0.78–1.64) | 0.63 (0.83–1.75) | 0.63 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.91 (0.68–1.21) | 0.95 (0.72–1.26) | 1.05 (0.80–1.38) | 0.96 (0.73–1.27) | 0.79 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.98 (1.03–3.80) | 1.67 (0.84–3.30) | 1.41 (0.69–2.87) | 1.42 (0.69–2.94) | 0.73 |
 Other cancer | ||||||
  No. of deaths | 78 | 103 | 107 | 98 | 124 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.31 (0.97–1.75) | 1.36 (1.02–1.83) | 1.19 (0.88–1.60) | 1.57 (1.18–2.08) | 0.01 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.29 (0.96–1.74) | 1.32 (0.96–1.74) | 1.12 (0.83–1.52) | 1.40 (1.04–1.89) | 0.11 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.30 (0.88–1.90) | 1.18 (0.80–1.73) | 1.10 (0.75–1.64) | 1.37 (0.94–2.01) | 0.27 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.29 (0.78–2.02) | 1.43 (0.90–2.27) | 1.09 (0.68–1.77) | 1.28 (0.79–2.07) | 0.55 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.21 (0.86–1.70) | 1.27 (0.91–1.77) | 1.13 (0.81–2.59) | 1.35 (0.97–1.89) | 0.15 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.55 (0.84–2.87) | 1.50 (0.79–2.82) | 0.97 (0.47–1.99) | 1.39 (0.70–2.77) | 0.80 |
Flavanones | ||||||
 Cancer | ||||||
  No. of deaths | 287 | 238 | 231 | 196 | 200 |  |
  Age-adjusted HR (95% CI) a | 1 | 0.88 (0.74–1.00) | 0.89 (0.74–1.06) | 0.77 (0.64–0.92) | 0.80 (0.66–0.95) | 0.004 |
  Multivariate-adjusted HR (95% CI) b | 1 | 0.87 (0.73–1.04) | 0.88 (0.74–1.05) | 0.78 (0.65–0.94) | 0.85 (0.70–1.03) | 0.04 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.81 (0.64–1.04) | 0.90 (0.71–1.14) | 0.86 (0.67–1.10) | 0.89 (0.69–1.16) | 0.54 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.93 (0.73–1.20) | 0.88 (0.68–1.15) | 0.74 (0.55–0.99) | 0.85 (0.63–1.14) | 0.09 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.92 (0.76–1.10) | 0.91 (0.75–1.10) | 0.79 (0.64–0.98) | 0.88 (0.71–1.09) | 0.09 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.55 (0.34–0.88) | 0.64 (0.42–1.00) | 0.58 (0.38–0.91) | 0.55 (0.35–0.86) | 0.02 |
 GI cancer | ||||||
  No. of deaths | 154 | 148 | 132 | 109 | 99 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.04 (0.83–1.30) | 0.96 (0.76–1.22) | 0.81 (0.64–1.04) | 0.75 (0.58–0.97) | 0.007 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.02 (0.81–1.28) | 0.96 (0.76–1.22) | 0.84 (0.65–1.08) | 0.85 (0.65–1.11) | 0.09 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.83 (0.59–1.18) | 1.08 (0.78–1.50) | 0.88 (0.62–1.26) | 0.96 (0.66–1.39) | 0.23 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.22 (0.90–1.66) | 0.85 (0.60–1.21) | 0.84 (0.58–1.22) | 0.72 (0.51–1.13) | 0.04 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.05 (0.83–1.34) | 0.91 (0.70–1.17) | 0.79 (0.59–1.04) | 0.80 (0.60–1.08) | 0.02 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.61 (0.28–1.33) | 1.07 (0.56–2.04) | 0.88 (0.46–1.71) | 0.80 (0.40–1.60) | 0.86 |
 Other cancer | ||||||
  No. of deaths | 133 | 90 | 99 | 87 | 101 |  |
  Age-adjusted HR (95% CI) a | 1 | 0.71 (0.54–0.93) | 0.80 (0.62–1.04) | 0.72 (0.55–0.95) | 0.84 (0.65–1.09) | 0.22 |
  Multivariate-adjusted HR (95% CI) b | 1 | 0.70 (0.53–0.91) | 0.79 (0.61–1.04) | 0.72 (0.55–0.96) | 0.83 (0.63–1.11) | 0.24 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.79 (0.56–1.12) | 0.73 (0.51–1.04) | 0.84 (0.59–1.19) | 0.82 (0.56–1.19) | 0.38 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.54 (0.34–0.85) | 0.92 (0.62–1.38) | 0.60 (0.38–0.97) | 0.96 (0.62–1.48) | 0.84 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.73 (0.54–0.99) | 0.91 (0.68–1.22) | 0.81 (0.59–1.11) | 0.97 (0.71–1.33) | 0.97 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.51 (0.28–0.93) | 0.39 (0.21–0.74) | 0.41 (0.22–0.76) | 0.41 (0.22–0.76) | 0.004 |
Flavones | ||||||
 Cancer | ||||||
  No. of deaths | 285 | 225 | 225 | 199 | 219 |  |
  Age-adjusted HR (95% CI) a | 1 | 0.84 (0.71–1.00) | 0.88 (0.74–1.05) | 0.77 (0.65–0.93) | 0.86 (0.72–1.03) | 0.06 |
  Multivariate-adjusted HR (95% CI) b | 1 | 0.82 (0.69–0.98) | 0.84 (0.70–1.01) | 0.74 (0.61–0.90) | 0.85 (0.70–1.04) | 0.05 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.86 (0.67–1.09) | 0.81 (0.63–1.04) | 0.73 (0.56–0.94) | 0.81 (0.62–1.06) | 0.06 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.76 (0.58–0.99) | 0.87 (0.67–1.14) | 0.76 (0.57–1.02) | 0.95 (0.71–1.27) | 0.66 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.83 (0.69–1.01) | 0.90 (0.74–1.10) | 0.71 (0.57–0.88) | 0.90 (0.72–1.12) | 0.13 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.74 (0.47–1.16) | 0.54 (0.33–0.87) | 0.76 (0.49–1.18) | 0.58 (0.36–0.93) | 0.06 |
 GI cancer | ||||||
  No. of deaths | 159 | 130 | 125 | 116 | 113 |  |
  Age-adjusted HR (95% CI) a | 1 | 0.89 (0.70–1.12) | 0.90 (0.71–1.14) | 0.83 (0.65–1.06) | 0.82 (0.64(−1.05) | 0.09 |
  Multivariate-adjusted HR (95% CI) b | 1 | 0.86 (0.68–1.09) | 0.85 (0.66–1.08) | 0.79 (0.61–1.02) | 0.84 (0.64–1.10) | 0.15 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.94 (0.67–1.31) | 0.78 (0.55–1.11) | 0.73 (0.51–1.06) | 0.79 (0.54–1.16) | 0.09 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.76 (0.54–1.08) | 0.92 (0.65–1.29) | 0.85 (0.59–1.22) | 0.90 (0.61–1.32) | 0.73 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.85 (0.66–1.09) | 0.90 (0.69–1.16) | 0.76 (0.57–1.01) | 0.86 (0.64–1.16) | 0.21 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.91 (0.48–1.71) | 0.56 (0.28–1.14) | 0.81 (0.43–1.53) | 0.59 (0.30–1.17) | 0.14 |
 Other cancer | ||||||
  No. of deaths | 126 | 95 | 100 | 83 | 106 |  |
  Age-adjusted HR (95% CI) a | 1 | 0.79 (0.60–1.03) | 0.86 (0.66–1.12) | 0.70 (0.53–0.93) | 0.91 (0.70–1.19) | 0.33 |
  Multivariate-adjusted HR (95% CI) b | 1 | 0.77 (0.59–1.02) | 0.83 (0.63–1.09) | 0.68 (0.50–0.91) | 0.86 (0.64–1.16) | 0.21 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.78 (0.54–1.11) | 0.84 (0.59–1.19) | 0.71 (0.49–1.04) | 0.82 (0.56–1.21) | 0.30 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.75 (0.49–1.15) | 0.80 (0.52–1.25) | 0.63 (0.39–1.03) | 1.02 (0.65–1.60) | 0.77 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.82 (0.61–1.11) | 0.92 (0.68–1.24) | 0.64 (0.46–0.90) | 0.95 (0.68–1.31) | 0.38 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.59 (0.31–1.13) | 0.52 (0.26–1.00) | 0.73 (0.40–1.33) | 0.57 (0.30–1.11) | 0.24 |
Isoflavnoids | ||||||
 Cancer | ||||||
  No. of deaths | 287 | 272 | 208 | 196 | 190 |  |
  Age-adjusted HR (95% CI) a | 1 | 0.99 (0.84–1.17) | 0.79 (0.66–0.94) | 0.78 (0.65–0.93) | 0.77 (0.64–0.93) | < 0.001 |
  Multivariate-adjusted HR (95% CI) b | 1 | 0.96 (0.81–1.14) | 0.77 (0.64–0.93) | 0.79 (0.66–0.96) | 0.82 (0.68–0.98) | 0.006 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.97 (0.77–1.22) | 0.72 (0.56–0.92) | 0.76 (0.59–0.97) | 0.73 (0.56–0.94) | 0.002 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.93 (0.72–1.19) | 0.83 (0.63–1.08) | 0.81 (0.61–1.08) | 0.90 (0.67–1.19) | 0.22 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.99 (0.83–1.19) | 0.81 (0.66–0.99) | 0.81 (0.66–1.00) | 0.85 (0.65–1.05) | 0.02 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.72 (0.47–1.10) | 0.55 (0.35–0.86) | 0.60 (0.39–0.94) | 0.60 (0.38–0.95) | 0.02 |
 GI cancer | ||||||
  No. of deaths | 159 | 162 | 126 | 103 | 93 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.08 (0.87–1.34) | 0.88 (0.69–1.11) | 0.76 (0.59–0.97) | 0.70 (0.54–0.91) | < 0.001 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.03 (0.83–1.29) | 0.87 (0.69–1.11) | 0.81 (0.63–1.04) | 0.80 (0.61–1.04) | 0.02 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.03 (0.76–1.40) | 0.72 (0.51–1.02) | 0.74 (0.52–1.05) | 0.64 (0.44–0.93) | 0.003 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.02 (0.74–1.04) | 1.01 (0.72–1.41) | 0.84 (0.58–1.22) | 0.96 (0.66–1.39) | 0.53 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.07 (0.84–1.36) | 0.92 (0.71–1.19) | 0.84 (0.63–1.11) | 0.86 (0.65–1.15) | 0.10 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.74 (0.41–1.32) | 0.55 (0.30–1.02) | 0.54 (0.29–1.01) | 0.46 (0.23–0.92) | 0.01 |
 Other cancer | ||||||
  No. of deaths | 128 | 110 | 82 | 93 | 97 |  |
  Age-adjusted HR (95% CI) a | 1 | 0.88 (0.68–1.14) | 0.68 (0.51–0.89) | 0.80 (0.61–1.04) | 0.86 (0.66–1.12) | 0.15 |
  Multivariate-adjusted HR (95% CI) b | 1 | 0.87 (0.67–1.12) | 0.66 (0.49–0.88) | 0.58 (0.58–1.01) | 0.63 (0.63–1.10) | 0.10 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.90 (0.64–1.27) | 0.71 (0.49–1.03) | 0.77 (0.54–1.11) | 0.81 (0.57–1.16) | 0.17 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.81 (0.54–1.21) | 0.58 (0.37–0.91) | 0.77 (0.49–1.19) | 0.81 (0.52–1.25) | 0.24 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.89 (0.67–1.19) | 0.68 (0.49–0.93) | 0.77 (0.56–1.05) | 0.84 (0.61–1.13) | 0.12 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.70 (0.37–1.30) | 0.55 (0.29–1.06) | 0.68 (0.37–1.26) | 0.76 (0.40–1.42) | 0.42 |
Anthocianidins | ||||||
 Cancer | ||||||
  No. of deaths | 202 | 210 | 237 | 247 | 257 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.07 (0.88–1.30) | 1.20 (0.99–1.45) | 1.22 (1.01–1.47) | 1.31 (1.09–1.58) | 0.001 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.05 (0.86–1.27) | 1.13 (0.93–1.36) | 1.09 (0.90–1.32) | 1.12 (0.92–1.36) | 0.23 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.89 (0.68–1.16) | 1.03 (0.80–1.33) | 1.01 (0.78–1.30) | 1.00 (0.77–1.30) | 0.64 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.20 (0.90–1.60) | 1.15 (0.87–1.54) | 1.09 (0.81–1.45) | 1.11 (0.83–1.50) | 0.73 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.02 (0.82–1.27) | 1.09 (0.88–1.35) | 1.09 (0.88–1.35) | 1.10 (0.89–1.21) | 0.27 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.00 (0.62–1.62) | 1.17 (0.74–1.87) | 1.26 (0.80–1.99) | 0.99 (0.62–1.60) | 0.77 |
 GI cancer | ||||||
  No. of deaths | 121 | 111 | 127 | 151 | 133 |  |
  Age-adjusted HR (95% CI) a | 1 | 0.96 (0.74–1.24) | 1.09 (0.85–1.40) | 1.26 (0.99–1.61) | 1.15 (0.90–1.47) | 0.04 |
  Multivariate-adjusted HR (95% CI) b | 1 | 0.93 (0.72–1.21) | 0.99 (0.77–1.28) | 1.06 (0.83–1.36) | 0.93 (0.72–1.21) | 0.99 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.76 (0.53–1.10) | 0.96 (0.68–1.36) | 0.94 (0.67–1.33) | 0.73 (0.50–1.05) | 0.31 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.08 (0.75–1.55) | 0.93 (0.64–1.35) | 1.08 (0.76–1.55) | 1.04 (0.72–1.51) | 0.80 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 0.88 (0.66–1.17) | 0.96 (0.73–1.27) | 1.04 (0.80–1.36) | 0.92 (0.69–1.21) | 0.99 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.69 (0.58–2.34) | 1.51 (0.77–2.94) | 1.35 (0.69–2.65) | 1.37 (0.70–2.66) | 0.63 |
 Other cancer | ||||||
  No. of deaths | 81 | 99 | 110 | 96 | 124 |  |
  Age-adjusted HR (95% CI) a | 1 | 1.24 (0.92–1.66) | 1.36 (1.02–1.82) | 1.17 (0.87–1.57) | 1.55 (1.17–2.05) | 0.09 |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.23 (0.21–1.65) | 1.32 (0.99–1.77) | 1.11 (0.82–1.50) | 1.41 (1.05–1.89) | 0.08 |
 Age | ||||||
   < 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.05 (0.71–1.54) | 1.11 (0.76–1.62) | 1.07 (0.73–1.57) | 1.38 (0.95–2.00) | 0.10 |
   > 60 years |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.45 (0.91–2.32) | 1.58 (1.00–2.50) | 1.08 (0.66–1.76) | 1.25 (0.77–2.05) | 0.82 |
 BMI | ||||||
   < 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.26 (0.90–1.77) | 1.31 (0.94–1.83) | 1.17 (0.83–1.42) | 1.42 (1.02–1.99) | 0.10 |
   > 30 |  |  |  |  |  |  |
  HR (95% CI) b | 1 | 1.07 (0.58–1.99) | 1.35 (0.74–2.46) | 0.81 (0.40–1.63) | 1.15 (0.59–2.23) | 0.94 |
Dihydrochalcones | ||||||
 Cancer | ||||||
  No. of deaths | 506 | 220 | 228 | 199 |  | |
  Age-adjusted HR (95% CI) a | 1 | 0.68 (0.53–0.89) | 0.96 (0.77–1.21) | 0.83 (0.65–1.05) | 0.24 | |
  Multivariate-adjusted HR (95% CI) b | 1 | 0.88 (0.75–1.03) | 0.89 (0.76–1.04) | 0.84 (0.71–0.99) | 0.03 | |
 Age | ||||||
   < 60 years |  |  |  |  |  | |
  HR (95% CI) b | 1 | 0.78 (0.62–0.97) | 0.99 (0.80–1.21) | 0.80 (0.64–1.01) | 0.95 | |
   > 60 years |  |  |  |  |  | |
  HR (95% CI) b | 1 | 1.01 (0.80–1.28) | 0.81 (0.63–1.04) | 0.94 (0.74–1.21) | 0.31 | |
 BMI | ||||||
   < 30 |  |  |  |  |  | |
  HR (95% CI) b | 1 | 0.84 (0.71–1.00) | 0.87 (0.73–1.04) | 0.84 (0.69–1.01) | 0.04 | |
   > 30 |  |  |  |  |  | |
  HR (95% CI) b | 1 | 1.04 (0.70–1.53) | 0.97 (0.66–1.42) | 0.75 (0.51–1.12) | 0.20 | |
 GI cancer | ||||||
  No. of deaths | 278 | 143 | 117 | 105 |  | |
  Age-adjusted HR (95% CI) a | 1 | 0.89 (0.76–1.04) | 0.89 (0.76–1.05) | 0.79 (0.67–0.93) | 0.006 | |
  Multivariate-adjusted HR (95% CI) b | 1 | 1.05 (0.86–1.29) | 0.84 (0.67–1.04) | 0.85 (0.67–1.07) | 0.07 | |
 Age | ||||||
   < 60 years |  |  |  |  |  | |
  HR (95% CI) b | 1 | 0.91 (0.68–1.21) | 0.82 (0.60–1.10) | 0.84 (0.61–1.16) | 0.17 | |
   > 60 years |  |  |  |  |  | |
  HR (95% CI) b | 1 | 1.20 (0.90–1.60) | 0.90 (0.65–1.23) | 0.88 (0.63–1.23) | 0.26 | |
 BMI | ||||||
   < 30 |  |  |  |  |  | |
  HR (95% CI) b | 1 | 1.04 (0.83–1.29) | 0.79 (0.62–1.01) | 0.85 (0.66–1.09) | 0.07 | |
   > 30 |  |  |  |  |  | |
  HR (95% CI) b | 1 | 1.08 (0.62–1.87) | 1.09 (0.64–1.85) | 0.73 (0.41–1.29) | 0.40 | |
 Other cancer | ||||||
  No. of deaths | 228 | 77 | 111 | 94 |  | |
  Age-adjusted HR (95% CI) a | 1 | 1.05 (0.86–1.29) | 0.84 (0.67–1.04) | 0.76 (0.61–0.95) | 0.009 | |
  Multivariate-adjusted HR (95% CI) b | 1 | 0.67 (0.52–0.87) | 0.96 (0.76–1.20) | 0.83 (0.65–1.07) | 0.26 | |
 Age | ||||||
   < 60 years |  |  |  |  |  | |
  HR (95% CI) b | 1 | 0.63 (0.45–0.89) | 1.18 (0.89–1.56) | 0.77 (0.55–1.08) | 0.58 | |
   > 60 years |  |  |  |  |  | |
  HR (95% CI) b | 1 | 0.75 (0.50–1.12) | 0.68 (0.45–1.03) | 1.03 (0.71–1.49) | 0.63 | |
BMI | ||||||
<30 | Â | Â | Â | Â | Â | |
HR (95% CI) b | 1 | 0.60 (0.44–0.81) | 0.98 (0.76–1.26) | 0.83 (0.63–1.09) | 0.35 | |
>30 | Â | Â | Â | Â | Â | |
HR (95% CI) b | 1 | 1.01 (0.59–1.73) | 0.85 (0.49–1.48) | 0.80 (0.46–1.38) | 0.37 |